Skip to main content Skip to main navigation Skip to search Skip to footer

Plotting Pharma Right

introduction to the topic

With the significant rise in the number of reported 'adverse' events, coupled with the paucity of 'blockbuster' drugs in the pipeline, global Pharma today faces an increased scrutiny from the FDA. Moreover, with the challenge to respond to an increasingly complex environment, driven by patient-centric care and outcome-based methodologies, the industry will need to undergo a radical overhaul.

With expertise across the entire Pharma value chain – right from drug discovery to sales and marketing, backed by end-to-end IT solutions – HCL today works with 9 of the top 10 global Pharma companies. HCL has infused the right mix of domain and technology to deliver value consistently to its clients year after year. Our strong domain offerings, with a focus on delivering 'the full life cycle' solutions, have both customers and prospects asking for more.

With the objective of discussing the challenges facing the global Pharma industry today, HCL's path-breaking work in the field and the way forward, we are hosting a webinar on Saturday, September 17, 2011.

Excited to know more about HCL's pioneering role in global Pharma?

 

About the speaker

Shiva

Shiva
Vice President

Shiva Subramaniam has an experience of over 15 years in IT services for Life Sciences and Integrated Health Domain. He currently drives and manages the Pharma practice in HCL Technologies.

Shiva has a Bachelors' degree in Engineering from the Institute of Technology Banaras Hindu University, Varanasi, India and a Post Graduate Diploma in Business Management from the Indian Institute of Management Ahmedabad.

He has set up a partnership with the Imperial College, London for joint work on Disease Management and Healthcare Records.

Saturday 17th September 2011

REGISTER FOR RECORDED WEBINAR

Contact Us
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.